F.D.A. advisers voted that the benefits of a nonprescription pill outweigh the risks. If the agency decides to move on the recommendation, the progestin-only contraceptive could be in stores within a few months.
Five years ago, a small group of cancer scientists meeting at a restaurant in a deconsecrated church hospital in Mainz, Germany, drew up an audacious plan: They would test their novel cancer vaccine against one of the most virulent forms of the disease, a cancer notorious for roaring back even in patients whose tumors had…
More than 20 years after scientists first released a draft sequence of the human genome, the book of life has been given a long-overdue rewrite. A more accurate and inclusive edition of our genetic code was published on Wednesday, marking a major step toward a deeper understanding of human biology and personalized medicine for people…
Research suggests that many fitness-themed Instagram accounts risk doing more harm than good. Here’s how to find #fitspiration you can trust.
Put off by her fiancé’s request for a prenuptial agreement after years of paying her own way, a reader is finding that resentment is crowding out her excitement.
On Thursday, three years and 100 days after the Trump administration declared the coronavirus a public health emergency, the Biden administration will allow the emergency declaration to expire, ushering in a new era when the government will treat Covid-19 like any other respiratory ailment. If the coronavirus pandemic was a war, the United States is…
It was like a tale of two birth control pills. At a hearing Tuesday to consider whether the Food and Drug Administration should authorize the country’s first over-the-counter birth control pill, a panel of independent medical experts advising the agency was left to reckon with two contradictory analyses of the medication called Opill. During the…
Alarmed by an increase in breast cancer diagnoses among younger women and persistently high death rates among Black women in particular, health experts on Tuesday offered a stark revision to the standard medical advice on mammograms. Women of all racial and ethnic backgrounds who are at average risk for breast cancer should start getting regular…
A jury sided with Gilead Sciences in a dispute over whether the government could claim a share of profits from drugs seen as crucial to ending the H.I.V. epidemic.
The U.S. Preventive Services Task Force, a panel of experts that issues guidelines about preventive care, has recommended all women start routine breast cancer screening at 40, instead of by 50, the previous recommendation. The panel continues to advise spacing the screenings at two-year intervals, although some other medical organizations endorse annual mammograms. Here’s more…